Self-report data as a tool for subtype identification in genetically-defined Parkinson’s Disease

[1]  M. Leite,et al.  Clinical profiles associated with LRRK2 and GBA mutations in Brazilians with Parkinson's disease , 2017, Journal of the Neurological Sciences.

[2]  M. Nalls,et al.  A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci , 2017, Nature Genetics.

[3]  E. Tolosa,et al.  Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestry , 2017, Movement disorders : official journal of the Movement Disorder Society.

[4]  Donal N. Gorman,et al.  GWAS of self-reported mosquito bite size, itch intensity and attractiveness to mosquitoes implicates immune-related predisposition loci , 2017, Human molecular genetics.

[5]  G. Rouleau,et al.  LRRK2 mutations in Parkinson disease; a sex effect or lack thereof? A meta-analysis. , 2015, Parkinsonism & related disorders.

[6]  K. Marder,et al.  Differential effects of severe vs mild GBA mutations on Parkinson disease , 2015, Neurology.

[7]  Chuong B. Do,et al.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.

[8]  M. Rudzińska,et al.  Cognitive impairment in carriers of glucocerebrosidase gene mutation in Parkinson disease patients. , 2014, Neurologia i neurochirurgia polska.

[9]  P. Mazzoni,et al.  Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations , 2013, Movement disorders : official journal of the Movement Disorder Society.

[10]  Nir Giladi,et al.  Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation , 2013, Movement disorders : official journal of the Movement Disorder Society.

[11]  K. Marder,et al.  Cognitive performance of GBA mutation carriers with early-onset PD , 2012, Neurology.

[12]  P. Pollak,et al.  Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers , 2012, Neurology.

[13]  Nicholas Eriksson,et al.  Novel Associations for Hypothyroidism Include Known Autoimmune Risk Loci , 2011, PloS one.

[14]  Nicholas Eriksson,et al.  Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease , 2011, PLoS genetics.

[15]  Jeffrey M. Hausdorff,et al.  Gait alterations in healthy carriers of the LRRK2 G2019S mutation , 2011, Annals of neurology.

[16]  Brian T. Naughton,et al.  Web-Based, Participant-Driven Studies Yield Novel Genetic Associations for Common Traits , 2010, PLoS genetics.

[17]  K. Marder,et al.  Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. , 2009, Archives of neurology.

[18]  M. Nalls,et al.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. , 2009, The New England journal of medicine.

[19]  E. Tolosa,et al.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.

[20]  K. Marder,et al.  Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease , 2007, Neurology.

[21]  C. Ross,et al.  Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Farrer,et al.  LRRK2 mutations in Parkinson disease , 2005, Neurology.

[23]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[24]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[25]  R. Schiffmann,et al.  Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? , 2003, Molecular genetics and metabolism.

[26]  Nir Giladi,et al.  Occurrence of Parkinson's syndrome in type I Gaucher disease. , 1996, QJM : monthly journal of the Association of Physicians.

[27]  E. Sidransky,et al.  Glucocerebrosidase mutations in subjects with parkinsonism. , 2004, Molecular genetics and metabolism.

[28]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .